indazoles has been researched along with Pancreatitis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Sütcüoğlu, O; Unsal, O; Yazıcı, O | 1 |
Kobayashi, T; Kodama, Y; Koma, YI; Masuda, A; Nakano, R; Sakai, A; Shigeoka, M; Shiomi, H; Tanaka, S; Tanaka, T | 1 |
Beaufils, B; Binnie, M; Bouillot, A; Denis, AA; Hann, MM; Haslam, CP; Holmes, DS; Hutchinson, JP; Kranz, M; Liddle, J; McBride, A; Mirguet, O; Mole, DJ; Mowat, CG; Pal, S; Rowland, P; Trottet, L; Uings, IJ; Walker, AL; Webster, SP | 1 |
Khenifer, S; Pasquet, F; Pavic, M; Péron, J; Potier, V; Rassat, R; Vitry, T | 1 |
Daido, Y; Kitamura, Y; Nishimoto, K; Shinchi, Y; Takao, M; Tokonabe, S; Yoshii, H | 1 |
Chen, JP; Ding, XL; Qiang, H; Wei, Q; Zhang, H; Zhang, HF; Zhou, GX; Zhu, XJ | 1 |
Cleary, J; Howard, SA; Jagannathan, JP; Krajewski, KM; O'Regan, K; Ramaiya, N; Thornton, E | 1 |
Bhatia, M; Chevali, L; Guglielmotti, A; Ramnath, RD | 1 |
8 other study(ies) available for indazoles and Pancreatitis
Article | Year |
---|---|
Dangerous interaction of bitter melon (
Topics: Acute Disease; Aged; Herb-Drug Interactions; Humans; Indazoles; Male; Momordica charantia; Pancreatitis; Plant Extracts; Pyrimidines; Sulfonamides | 2022 |
An autopsy case of severe acute pancreatitis induced by administration of pazopanib following nivolumab.
Topics: Aged; Fatal Outcome; Female; Humans; Indazoles; Methylprednisolone; Nivolumab; Pancreatitis; Pyrimidines; Sulfonamides | 2021 |
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.
Topics: Animals; Benzoxazoles; Drug Discovery; Enzyme Inhibitors; HEK293 Cells; Humans; Indazoles; Kynurenine; Kynurenine 3-Monooxygenase; Pancreatitis; Rats; Tryptophan | 2017 |
Axitinib-induced acute pancreatitis: a case report.
Topics: Acute Disease; Adult; Antineoplastic Agents; Axitinib; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Pancreatitis; Protein Kinase Inhibitors | 2014 |
A Case of Pancreatic Side Effects Resulting from Sorafenib and Axitinib Treatment of Stage IV Renal Cell Carcinoma.
Topics: Antineoplastic Agents; Axitinib; Carcinoma, Renal Cell; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Niacinamide; Pancreatitis; Phenylurea Compounds; Sorafenib | 2015 |
Protective effects of MCP-1 inhibitor on a rat model of severe acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Chemokine CCL2; Immunohistochemistry; Indazoles; Male; Pancreas; Pancreatitis; Propionates; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2010 |
Decade of molecular targeted therapy: abdominal manifestations of drug toxicities--what radiologists should know.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Chemical and Drug Induced Liver Injury; Cholecystitis; Early Diagnosis; Edema; Fatty Liver; Female; Health Knowledge, Attitudes, Practice; Humans; Indazoles; Infections; Male; Middle Aged; Molecular Targeted Therapy; Neoplasms; Pancreatitis; Protein-Tyrosine Kinases; Pyrimidines; Radiography, Abdominal; Sulfonamides; Vascular Endothelial Growth Factor A; Young Adult | 2012 |
Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis.
Topics: Acute Disease; Animals; Ceruletide; Chemokine CCL2; Disease Models, Animal; Indazoles; Inflammation; Mice; Necrosis; Pancreas; Pancreatitis; Propionates | 2005 |